A lymphoma drug undergoing a phase 3 clinical trial hopes to make multiple sclerosis relapses five times less likely.
Lymphoma Drug Undergoing Trial Makes MS Relapses 5 Times Less Likely
by | Jul 20, 2022 | Uncategorized | 0 comments
Recent Posts
- Cosmetic Surgery Costs Are Soaring, but Here’s How Patients Are Paying for It
- The Mental Health Impact Of Major Life Transitions
- Vietnam Reaches Medical Milestone With First Robotic Brain Surgery on Child with Drug-Resistant Epilepsy
- Marjorie Taylor Greene Calls Out ‘Absolutely Unaffordable’ Insurance Prices After Voting to Kick Millions Off Their Insurance
- No Jail for Texas Mom Accused of Medical Child Abuse in Munchausen by Proxy Case
Archives
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- February 2024
- January 2024
- December 2023
- September 2023
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
Recent Comments